BIOLASE Inc (NASDAQ:BIOL)
| 1.52 Delayed Data As of Dec 04 |  +0.365 / +31.74%Today’s Change | 1.07 Today|||52-Week Range 88.66 | -97.67% Year-to-Date |
Latest BIOL News | Press Releases
No recent news for BIOLASE Inc.
Today’s Trading
| Previous close | 1.15 |
| Today’s open | 1.19 |
| Day’s range | 1.19 - 1.63 |
| Volume | 46,841 |
| Average volume (3 months) | 355,275 |
| Market cap | $2.7M |
Data as of 3:59pm ET, 12/04/2023
Growth & Valuation
| Earnings growth (last year) | -47.29% |
| Earnings growth (this year) | +99.94% |
| Earnings growth (next 5 years) | +11.00% |
| Revenue growth (last year) | +23.67% |
| P/E ratio | NM |
| Price/Sales | 0.09 |
| Price/Book | 0.02 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RIGHRightSmile Inc | 0.00 | 0.00% |
| ---- | ||
| --Lancer Orthodontics ... | 0.00 | 0.00% |
| ---- |
Data as of 11/20/2023
Financials
| Next reporting date | March 14, 2024 |
| EPS forecast (this quarter) | -$0.02 |
| Annual revenue (last year) | $48.5M |
| Annual profit (last year) | -$28.6M |
| Net profit margin | -59.09% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Lake Forest, California |
Forecasts
